FindTrial
Sign In

Effect Of Majoon Hajrul Yahood In Patient Of Hasat-E-Bauliyah (stone in urinary tract)

Therapeutic Effect Of Majoon Hajrul Yahood In Patient Of Hasat-E-Bauliyah(Urolithiasis)- A Randomised Placebo Control Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041206
Enrollment
45
Registered
2022-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

Intervention1: Majoon Hajrul Yahood: Content of Majoon Hajrul Yahood hab kaknaj 15grams hajrul yahood 150grams maghz tukh

Sponsors

National Institute Of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with the urinary stones of size less than 10 mm diagnosed by Ultrasonography of Whole Abdomen & Pelvis Both Symptomatic and Asymptomatic urolithiasis patients Only stable cases of urolithiasis will be enlisted

Exclusion criteria

Exclusion criteria: Patients having the stone of size more than 10mm Urinary tract infection Severe Hydroureteronephrosis Dumble shape calyx Patients having any Severe Systemic Disease Pregnant and lactating Women Bladder outlet obstruction K/C/O Diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Improvement in the objective parameters Blood urea and Serum Creatinine Urine Routine and Microscopy USG-Abdomen pelvisTimepoint: 42 days—

Secondary

MeasureTime frame
Improvement in subjective parameters Pain in abdomen VAS Scoring Burning Micturation Hematuria Nausea VomitingTimepoint: 42 days—

Countries

India

Contacts

Public ContactMomin Afia Jameel Ahmed

National Institute Of Unani Medicine

fatimahmehjabeen@gmail.com8057438462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026